FDA approves an oral treatment for postpartum depression called zuranolone

The FDA announced Friday approval of an oral treatment for postpartum depression. The drug, called zuranolone, is a pill that is taken once a day. Roxana Saberi talks about how the pill can help women deal with one of the most common medical complications after pregnancy.